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Background
Diabetes mellitus (DM) is a common comorbidity of
Cushing’s syndrome (CS) and plays an important role
in morbidity and death of patients with uncontrolled
hypercortisolism. Some authors define DM in CS as a
‘specific type of diabetes secondary to endocrinopathy’,
although others judge it as a classical form of type 2
DM. Glucocorticoid (GC) excess causes pancreatic beta
cell dysfunction and insulin resistance, which correlates
with hypercortisolism level. If Cushing’s disease (CD)
remission implicates on DM resolution remains
unclear.
Objectives
To asses DM prevalence in CD patients and DM resolu-
tion rate after one year remission of CD.
Materials and methods
Retrospective cohort of 108 patients diagnosed with CD
between 1987 and 2014 at a tertiary endocrinology ser-
vice. Patients underwent clinical and metabolic evalua-
tion at diagnosis and after CD treatment. CD remission
criteria after transsphenoidal surgery were: cortisol < 3
mcg/dl on the 1mg-overnight test, normal urinary free
cortisol and/or adrenal insufficiency with GC depen-
dence for 6 months. DM resolution criteria were HbA1c
<6.5% and fasting glucose < 126mg/dL without antidia-
betic drugs.
Results
Patients clinical and biochemical features are presented
in Figure 1. Of the 108 CD patients, 38% had DM diag-
nosis and 32% were treated with hypoglycemic agents
and/or insulin. CD remission was achieved in 73% of
the diabetic patients and 66% were also considered
cured of DM after 1 year (p=0.378). There was no statis-
tically significant association between age, gender, body
mass index, lipid profile, 24h-UFC at diagnosis and DM
regression.
Discussion
In this representative CD sample, prevalence of DM was
consistent with literature, ranging from 30-50%. Only a
few reports analyze DM persistence after CD resolution
and possible cure predictors. No relationship was found
between DM and CD short term remission. Dysglycemia
may persist up to 5 yrs. after CD treatment, showing a
metabolic imprinting of chronic GC excess. DM resolu-
tion also depends on the weight loss, physical activity,
body composition and prolonged use of GC following
surgery.
Conclusion
DM affects up to 40% of patients with CD and its short
term remission does not seem to predict the resolution
of diabetes, perhaps because metabolic effects persists
even after correction of hypercortisolism and factors
associated with DM cure are heterogeneous.
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Figure 1 Clinical and Biochemical Features of the Patients with Cushing's disease and DM Data are expressed in mean (DP) or median
(P25-P75). BMI denotes body mass index; HDL high-density lipoprotein; A1c glycated hemoglobin
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